OTCMKTS:IMIAY - IMI Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 6 Buy Ratings
  • 1 Strong Buy Ratings
$35.73
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New IMI Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IMIAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IMIAY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for IMI in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $35.73.
Buy
The current consensus among 11 investment analysts is to buy stock in IMI. This rating has held steady since February 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/26/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/24/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/23/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/22/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/20/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/19/2020
  • 1 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/18/2021

Latest Recommendations

  • 1 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/18/2021The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy
i
1/15/2021Morgan StanleyReiterated RatingOverweight
i
1/13/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform
i
12/1/2020BNP ParibasDowngradeOutperform ➝ Neutral
i
12/1/2020Exane BNP ParibasDowngradeOutperform ➝ Neutral
i
11/24/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
i
10/29/2020Royal Bank of CanadaReiterated RatingOutperform
i
10/28/2020Jefferies Financial GroupReiterated RatingBuy
i
10/15/2020UBS GroupReiterated RatingNeutral
i
10/2/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight
i
9/9/2020Berenberg BankUpgradeSell ➝ Hold
i
6/18/2020UBS GroupReiterated RatingNeutral
i
3/23/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
3/11/2020Berenberg BankReiterated RatingSell
i
3/11/2020Morgan StanleyReiterated RatingEqual Weight
i
9/13/2019Berenberg BankInitiated CoverageSell
i
12/7/2018Credit Suisse GroupDowngradeNeutral ➝ Underperform
i
11/20/2018Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform
i
7/14/2018HSBCUpgradeHold ➝ Buy
i
5/10/2018Jefferies Financial GroupUpgradeHold ➝ Buy
i
4/24/2018Numis SecuritiesUpgradeHold ➝ Add
i
2/6/2018BNP ParibasDowngradeOutperform ➝ Neutral
i
1/9/2018Societe GeneraleUpgradeHold ➝ Buy
i
1/9/2018Bank of AmericaReiterated RatingBuy ➝ Neutral
i
2/22/2017Liberum CapitalInitiated CoverageBuy ➝ Buy
i
(Data available from 1/18/2016 forward)
IMI logo
IMI plc, a specialist engineering company, designs, manufactures, and services engineered products worldwide. The company operates through three divisions: IMI Precision Engineering, IMI Critical Engineering, and IMI Hydronic Engineering. The IMI Precision Engineering division develops motion and fluid control technologies for industrial automation, commercial vehicle, life sciences, energy, and rail applications. This division offers valves, valve islands, proportional and pressure monitoring controls, and air preparation products, as well as pneumatic actuators; cab chassis and powertrain solutions; stainless steel valves and regulators, nuclear class valves, and emergency shutdown controls; components for the rail industry; and precision flow control solutions that are used in medical devices, diagnostic equipment, and biotech and analytical instruments. It provides its products under the IMI Norgren, IMI Buschjost, IMI FAS, IMI Herion, IMI Maxseal, and Bimba brands. The IMI Critical Engineering division offers flow control solutions, such as specialized valves and actuators to the fossil power, oil and gas, petrochemical, nuclear, marine, and pharmaceutical markets under the IMI Bopp & Reuther, IMI CCI, IMI Fluid Kinetics, IMI InterAtiva, IMI NH, IMI Orton, IMI PBM, IMI Remosa, IMI STI, IMI TH Jansen, IMI Truflo Marine, IMI Truflo Rona, and IMI Z&J brands. The IMI Hydronic Engineering division provides products for hydronic distribution systems, which deliver heating and cooling systems to the residential and commercial building sectors. It offers balancing and control solutions, thermostatic control and pressurization systems, dirt and air separators, and pressure step degassers under the IMI Pneumatex, IMI TA, IMI Flow Design, and IMI Heimeier brands. The company was founded in 1862 and is headquartered in Birmingham, the United Kingdom.
Read More

Today's Range

Now: $35.73
$35.73
$35.73

50 Day Range

MA: $30.94
$28.65
$35.73

52 Week Range

Now: $35.73
$22.70
$35.73

Volume

N/A

Average Volume

41 shs

Market Capitalization

$4.86 billion

P/E Ratio

19.21

Dividend Yield

4.70%

Beta

0.35

Frequently Asked Questions

What sell-side analysts currently cover shares of IMI?

The following Wall Street research analysts have issued reports on IMI in the last year: Berenberg Bank, BNP Paribas, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Exane BNP Paribas, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, The Goldman Sachs Group, Inc., UBS Group AG, and Zacks Investment Research.

What is the current price target for IMI?

0 Wall Street analysts have set twelve-month price targets for IMI in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for IMI in the next year.

What is the current consensus analyst rating for IMI?

IMI currently has 4 hold ratings, 6 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IMIAY will outperform the market and that investors should add to their positions of IMI.

What other companies compete with IMI?

How do I contact IMI's investor relations team?

IMI's physical mailing address is Lakeside Solihull Parkway, Birmingham X0, B37 7XZ. The company's listed phone number is 44-12-1717-3700 and its investor relations email address is info@imiplc.com. The official website for IMI is www.imiplc.com.